CYP 450 2C19 polymorphisms in Indian patients with coronary artery disease.
about
Preemptive Genotyping of CYP2C8 and CYP2C9 Allelic Variants Involved in NSAIDs Metabolism for Sickle Cell Disease Pain ManagementA Critical Evaluation of Pharmacogenetic Information in Package Inserts for Selected Drugs Marketed in India and Its Comparison With US FDA-Approved Package Inserts.Pharmacogenomic Impact of CYP2C19 Variation on Clopidogrel Therapy in Precision Cardiovascular Medicine.
P2860
CYP 450 2C19 polymorphisms in Indian patients with coronary artery disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
CYP 450 2C19 polymorphisms in Indian patients with coronary artery disease.
@en
CYP 450 2C19 polymorphisms in Indian patients with coronary artery disease.
@nl
type
label
CYP 450 2C19 polymorphisms in Indian patients with coronary artery disease.
@en
CYP 450 2C19 polymorphisms in Indian patients with coronary artery disease.
@nl
prefLabel
CYP 450 2C19 polymorphisms in Indian patients with coronary artery disease.
@en
CYP 450 2C19 polymorphisms in Indian patients with coronary artery disease.
@nl
P2093
P2860
P1476
CYP 450 2C19 polymorphisms in Indian patients with coronary artery disease.
@en
P2093
Balram Bhargava
Sandeep Seth
Sivasubramanian Ramakrishnan
Sudhir S Shetkar
Sunil K Verma
Vinay K Bahl
P2860
P356
10.1016/J.IHJ.2013.10.001
P577
2013-11-06T00:00:00Z